BH3 mimetic ABT-737 sensitizes colorectal cancer cells to ixazomib through MCL-1 downregulation and autophagy inhibition
about
The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells.Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1.
P2860
BH3 mimetic ABT-737 sensitizes colorectal cancer cells to ixazomib through MCL-1 downregulation and autophagy inhibition
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
BH3 mimetic ABT-737 sensitizes ...... ation and autophagy inhibition
@en
BH3 mimetic ABT-737 sensitizes ...... tion and autophagy inhibition.
@nl
type
label
BH3 mimetic ABT-737 sensitizes ...... ation and autophagy inhibition
@en
BH3 mimetic ABT-737 sensitizes ...... tion and autophagy inhibition.
@nl
prefLabel
BH3 mimetic ABT-737 sensitizes ...... ation and autophagy inhibition
@en
BH3 mimetic ABT-737 sensitizes ...... tion and autophagy inhibition.
@nl
P2093
P2860
P1476
BH3 mimetic ABT-737 sensitizes ...... ation and autophagy inhibition
@en
P2093
Darryll Barkhouse
Guichao Li
Juefeng Wan
Lifeng Yang
Sheng Xiao
Zhen Zhang
P2860
P304
P577
2016-06-01T00:00:00Z